PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SBIO vs. XBI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between SBIO and XBI is 0.95, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.01.0

Performance

SBIO vs. XBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ALPS Medical Breakthroughs ETF (SBIO) and SPDR S&P Biotech ETF (XBI). The values are adjusted to include any dividend payments, if applicable.

40.00%50.00%60.00%70.00%80.00%JulyAugustSeptemberOctoberNovemberDecember
47.90%
49.42%
SBIO
XBI

Key characteristics

Sharpe Ratio

SBIO:

0.52

XBI:

0.41

Sortino Ratio

SBIO:

0.91

XBI:

0.74

Omega Ratio

SBIO:

1.10

XBI:

1.09

Calmar Ratio

SBIO:

0.30

XBI:

0.20

Martin Ratio

SBIO:

1.68

XBI:

1.29

Ulcer Index

SBIO:

9.05%

XBI:

8.18%

Daily Std Dev

SBIO:

29.33%

XBI:

25.90%

Max Drawdown

SBIO:

-63.06%

XBI:

-63.89%

Current Drawdown

SBIO:

-44.84%

XBI:

-47.44%

Returns By Period

In the year-to-date period, SBIO achieves a 6.29% return, which is significantly higher than XBI's 2.37% return.


SBIO

YTD

6.29%

1M

-5.78%

6M

5.08%

1Y

13.27%

5Y*

-3.88%

10Y*

N/A

XBI

YTD

2.37%

1M

-3.20%

6M

-1.05%

1Y

4.32%

5Y*

-1.28%

10Y*

4.32%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


SBIO vs. XBI - Expense Ratio Comparison

SBIO has a 0.50% expense ratio, which is higher than XBI's 0.35% expense ratio.


SBIO
ALPS Medical Breakthroughs ETF
Expense ratio chart for SBIO: current value at 0.50% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.50%
Expense ratio chart for XBI: current value at 0.35% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.35%

Risk-Adjusted Performance

SBIO vs. XBI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SBIO, currently valued at 0.52, compared to the broader market0.002.004.000.520.41
The chart of Sortino ratio for SBIO, currently valued at 0.91, compared to the broader market-2.000.002.004.006.008.0010.000.910.74
The chart of Omega ratio for SBIO, currently valued at 1.10, compared to the broader market0.501.001.502.002.503.001.101.09
The chart of Calmar ratio for SBIO, currently valued at 0.30, compared to the broader market0.005.0010.0015.000.300.20
The chart of Martin ratio for SBIO, currently valued at 1.68, compared to the broader market0.0020.0040.0060.0080.00100.001.681.29
SBIO
XBI

The current SBIO Sharpe Ratio is 0.52, which is comparable to the XBI Sharpe Ratio of 0.41. The chart below compares the historical Sharpe Ratios of SBIO and XBI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50JulyAugustSeptemberOctoberNovemberDecember
0.52
0.41
SBIO
XBI

Dividends

SBIO vs. XBI - Dividend Comparison

SBIO's dividend yield for the trailing twelve months is around 3.47%, more than XBI's 0.14% yield.


TTM20232022202120202019201820172016201520142013
SBIO
ALPS Medical Breakthroughs ETF
3.47%0.22%0.00%0.00%0.00%0.04%2.79%1.77%0.00%0.00%0.00%0.00%
XBI
SPDR S&P Biotech ETF
0.14%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%1.07%0.17%

Drawdowns

SBIO vs. XBI - Drawdown Comparison

The maximum SBIO drawdown since its inception was -63.06%, roughly equal to the maximum XBI drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for SBIO and XBI. For additional features, visit the drawdowns tool.


-50.00%-45.00%-40.00%-35.00%JulyAugustSeptemberOctoberNovemberDecember
-44.84%
-47.44%
SBIO
XBI

Volatility

SBIO vs. XBI - Volatility Comparison

ALPS Medical Breakthroughs ETF (SBIO) has a higher volatility of 9.71% compared to SPDR S&P Biotech ETF (XBI) at 7.92%. This indicates that SBIO's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%6.00%7.00%8.00%9.00%10.00%11.00%JulyAugustSeptemberOctoberNovemberDecember
9.71%
7.92%
SBIO
XBI
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab